COVID-19 Outbreak-Global Pneumonia Vaccine Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
Pneumonia vaccine is mainly to prevent pneumonia caused by pneumococcal disease.
The Pneumonia Vaccine market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Pneumonia Vaccine industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Pneumonia Vaccine market can be split based on product types, major applications, and important countries as follows:
Key players in the global Pneumonia Vaccine market covered in Chapter 12:
Serum Institute of India
Biken
Genentech
Eli Lilly
Sanofi
Celgene
Merck
S K Chemicals
Abera
ImmunoBiology
Lupin
Pfizer
Panacea Biotec (India)
Nuron Biotech
Baxter
GlaxoSmithKline (GSK)
AstraZeneca
Biogen
Valneva Austria
Beijing Minhai Biotechnology
Genocea Biosciences
Sinovac
In Chapter 4 and 14.1, on the basis of types, the Pneumonia Vaccine market from 2015 to 2025 is primarily split into:
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
In Chapter 5 and 14.2, on the basis of applications, the Pneumonia Vaccine market from 2015 to 2025 covers:
Pneumonia
Meningitis
Sepsis
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Pneumonia Vaccine Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Pneumonia Vaccine
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Pneumonia Vaccine industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Pneumonia Vaccine Market Size, 2015 – 2020
2.1.2 Global Pneumonia Vaccine Market Size by Type, 2015 – 2020
2.1.3 Global Pneumonia Vaccine Market Size by Application, 2015 – 2020
2.1.4 Global Pneumonia Vaccine Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Pneumonia Vaccine Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Pneumonia Vaccine Analysis
3.2 Major Players of Pneumonia Vaccine
3.3 Pneumonia Vaccine Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Pneumonia Vaccine
3.3.3 Labor Cost of Pneumonia Vaccine
3.4 Market Distributors of Pneumonia Vaccine
3.5 Major Downstream Buyers of Pneumonia Vaccine Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Pneumonia Vaccine Market, by Type
4.1 Global Pneumonia Vaccine Value and Market Share by Type (2015-2020)
4.2 Global Pneumonia Vaccine Production and Market Share by Type (2015-2020)
4.3 Global Pneumonia Vaccine Value and Growth Rate by Type (2015-2020)
4.3.1 Global Pneumonia Vaccine Value and Growth Rate of Pneumococcal Conjugate Vaccine (PCV13)
4.3.2 Global Pneumonia Vaccine Value and Growth Rate of Pneumococcal Polysaccharide Vaccine (PPSV23)
4.4 Global Pneumonia Vaccine Price Analysis by Type (2015-2020)
5 Pneumonia Vaccine Market, by Application
5.1 Downstream Market Overview
5.2 Global Pneumonia Vaccine Consumption and Market Share by Application (2015-2020)
5.3 Global Pneumonia Vaccine Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Pneumonia Vaccine Consumption and Growth Rate of Pneumonia (2015-2020)
5.3.2 Global Pneumonia Vaccine Consumption and Growth Rate of Meningitis (2015-2020)
5.3.3 Global Pneumonia Vaccine Consumption and Growth Rate of Sepsis (2015-2020)
6 Global Pneumonia Vaccine Market Analysis by Regions
6.1 Global Pneumonia Vaccine Sales, Revenue and Market Share by Regions
6.1.1 Global Pneumonia Vaccine Sales by Regions (2015-2020)
6.1.2 Global Pneumonia Vaccine Revenue by Regions (2015-2020)
6.2 North America Pneumonia Vaccine Sales and Growth Rate (2015-2020)
6.3 Europe Pneumonia Vaccine Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Pneumonia Vaccine Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Pneumonia Vaccine Sales and Growth Rate (2015-2020)
6.6 South America Pneumonia Vaccine Sales and Growth Rate (2015-2020)
7 North America Pneumonia Vaccine Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Pneumonia Vaccine Sales, Revenue and Market Share by Countries
7.2.1 North America Pneumonia Vaccine Sales by Countries (2015-2020)
7.2.2 North America Pneumonia Vaccine Revenue by Countries (2015-2020)
7.3 United States Pneumonia Vaccine Sales and Growth Rate (2015-2020)
7.4 Canada Pneumonia Vaccine Sales and Growth Rate (2015-2020)
7.5 Mexico Pneumonia Vaccine Sales and Growth Rate (2015-2020)
8 Europe Pneumonia Vaccine Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Pneumonia Vaccine Sales, Revenue and Market Share by Countries
8.2.1 Europe Pneumonia Vaccine Sales by Countries (2015-2020)
8.2.2 Europe Pneumonia Vaccine Revenue by Countries (2015-2020)
8.3 Germany Pneumonia Vaccine Sales and Growth Rate (2015-2020)
8.4 UK Pneumonia Vaccine Sales and Growth Rate (2015-2020)
8.5 France Pneumonia Vaccine Sales and Growth Rate (2015-2020)
8.6 Italy Pneumonia Vaccine Sales and Growth Rate (2015-2020)
8.7 Spain Pneumonia Vaccine Sales and Growth Rate (2015-2020)
8.8 Russia Pneumonia Vaccine Sales and Growth Rate (2015-2020)
9 Asia Pacific Pneumonia Vaccine Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Pneumonia Vaccine Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Pneumonia Vaccine Sales by Countries (2015-2020)
9.2.2 Asia Pacific Pneumonia Vaccine Revenue by Countries (2015-2020)
9.3 China Pneumonia Vaccine Sales and Growth Rate (2015-2020)
9.4 Japan Pneumonia Vaccine Sales and Growth Rate (2015-2020)
9.5 South Korea Pneumonia Vaccine Sales and Growth Rate (2015-2020)
9.6 India Pneumonia Vaccine Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Pneumonia Vaccine Sales and Growth Rate (2015-2020)
9.8 Australia Pneumonia Vaccine Sales and Growth Rate (2015-2020)
10 Middle East and Africa Pneumonia Vaccine Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Pneumonia Vaccine Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Pneumonia Vaccine Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Pneumonia Vaccine Revenue by Countries (2015-2020)
10.3 Saudi Arabia Pneumonia Vaccine Sales and Growth Rate (2015-2020)
10.4 UAE Pneumonia Vaccine Sales and Growth Rate (2015-2020)
10.5 Egypt Pneumonia Vaccine Sales and Growth Rate (2015-2020)
10.6 Nigeria Pneumonia Vaccine Sales and Growth Rate (2015-2020)
10.7 South Africa Pneumonia Vaccine Sales and Growth Rate (2015-2020)
11 South America Pneumonia Vaccine Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Pneumonia Vaccine Sales, Revenue and Market Share by Countries
11.2.1 South America Pneumonia Vaccine Sales by Countries (2015-2020)
11.2.2 South America Pneumonia Vaccine Revenue by Countries (2015-2020)
11.3 Brazil Pneumonia Vaccine Sales and Growth Rate (2015-2020)
11.4 Argentina Pneumonia Vaccine Sales and Growth Rate (2015-2020)
11.5 Columbia Pneumonia Vaccine Sales and Growth Rate (2015-2020)
11.6 Chile Pneumonia Vaccine Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Serum Institute of India
12.1.1 Serum Institute of India Basic Information
12.1.2 Pneumonia Vaccine Product Introduction
12.1.3 Serum Institute of India Production, Value, Price, Gross Margin 2015-2020
12.2 Biken
12.2.1 Biken Basic Information
12.2.2 Pneumonia Vaccine Product Introduction
12.2.3 Biken Production, Value, Price, Gross Margin 2015-2020
12.3 Genentech
12.3.1 Genentech Basic Information
12.3.2 Pneumonia Vaccine Product Introduction
12.3.3 Genentech Production, Value, Price, Gross Margin 2015-2020
12.4 Eli Lilly
12.4.1 Eli Lilly Basic Information
12.4.2 Pneumonia Vaccine Product Introduction
12.4.3 Eli Lilly Production, Value, Price, Gross Margin 2015-2020
12.5 Sanofi
12.5.1 Sanofi Basic Information
12.5.2 Pneumonia Vaccine Product Introduction
12.5.3 Sanofi Production, Value, Price, Gross Margin 2015-2020
12.6 Celgene
12.6.1 Celgene Basic Information
12.6.2 Pneumonia Vaccine Product Introduction
12.6.3 Celgene Production, Value, Price, Gross Margin 2015-2020
12.7 Merck
12.7.1 Merck Basic Information
12.7.2 Pneumonia Vaccine Product Introduction
12.7.3 Merck Production, Value, Price, Gross Margin 2015-2020
12.8 S K Chemicals
12.8.1 S K Chemicals Basic Information
12.8.2 Pneumonia Vaccine Product Introduction
12.8.3 S K Chemicals Production, Value, Price, Gross Margin 2015-2020
12.9 Abera
12.9.1 Abera Basic Information
12.9.2 Pneumonia Vaccine Product Introduction
12.9.3 Abera Production, Value, Price, Gross Margin 2015-2020
12.10 ImmunoBiology
12.10.1 ImmunoBiology Basic Information
12.10.2 Pneumonia Vaccine Product Introduction
12.10.3 ImmunoBiology Production, Value, Price, Gross Margin 2015-2020
12.11 Lupin
12.11.1 Lupin Basic Information
12.11.2 Pneumonia Vaccine Product Introduction
12.11.3 Lupin Production, Value, Price, Gross Margin 2015-2020
12.12 Pfizer
12.12.1 Pfizer Basic Information
12.12.2 Pneumonia Vaccine Product Introduction
12.12.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
12.13 Panacea Biotec (India)
12.13.1 Panacea Biotec (India) Basic Information
12.13.2 Pneumonia Vaccine Product Introduction
12.13.3 Panacea Biotec (India) Production, Value, Price, Gross Margin 2015-2020
12.14 Nuron Biotech
12.14.1 Nuron Biotech Basic Information
12.14.2 Pneumonia Vaccine Product Introduction
12.14.3 Nuron Biotech Production, Value, Price, Gross Margin 2015-2020
12.15 Baxter
12.15.1 Baxter Basic Information
12.15.2 Pneumonia Vaccine Product Introduction
12.15.3 Baxter Production, Value, Price, Gross Margin 2015-2020
12.16 GlaxoSmithKline (GSK)
12.16.1 GlaxoSmithKline (GSK) Basic Information
12.16.2 Pneumonia Vaccine Product Introduction
12.16.3 GlaxoSmithKline (GSK) Production, Value, Price, Gross Margin 2015-2020
12.17 AstraZeneca
12.17.1 AstraZeneca Basic Information
12.17.2 Pneumonia Vaccine Product Introduction
12.17.3 AstraZeneca Production, Value, Price, Gross Margin 2015-2020
12.18 Biogen
12.18.1 Biogen Basic Information
12.18.2 Pneumonia Vaccine Product Introduction
12.18.3 Biogen Production, Value, Price, Gross Margin 2015-2020
12.19 Valneva Austria
12.19.1 Valneva Austria Basic Information
12.19.2 Pneumonia Vaccine Product Introduction
12.19.3 Valneva Austria Production, Value, Price, Gross Margin 2015-2020
12.20 Beijing Minhai Biotechnology
12.20.1 Beijing Minhai Biotechnology Basic Information
12.20.2 Pneumonia Vaccine Product Introduction
12.20.3 Beijing Minhai Biotechnology Production, Value, Price, Gross Margin 2015-2020
12.21 Genocea Biosciences
12.21.1 Genocea Biosciences Basic Information
12.21.2 Pneumonia Vaccine Product Introduction
12.21.3 Genocea Biosciences Production, Value, Price, Gross Margin 2015-2020
12.22 Sinovac
12.22.1 Sinovac Basic Information
12.22.2 Pneumonia Vaccine Product Introduction
12.22.3 Sinovac Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Pneumonia Vaccine Market Forecast
14.1 Global Pneumonia Vaccine Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Pneumococcal Conjugate Vaccine (PCV13) Market Value and Volume Forecast (2020-2025)
14.1.2 Pneumococcal Polysaccharide Vaccine (PPSV23) Market Value and Volume Forecast (2020-2025)
14.2 Global Pneumonia Vaccine Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Pneumonia Market Value and Volume Forecast (2020-2025)
14.2.2 Meningitis Market Value and Volume Forecast (2020-2025)
14.2.3 Sepsis Market Value and Volume Forecast (2020-2025)
14.3 Pneumonia Vaccine Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Pneumonia Vaccine
Table Product Specification of Pneumonia Vaccine
Table Pneumonia Vaccine Key Market Segments
Table Key Players Pneumonia Vaccine Covered
Figure Global Pneumonia Vaccine Market Size, 2015 – 2025
Table Different Types of Pneumonia Vaccine
Figure Global Pneumonia Vaccine Value ($) Segment by Type from 2015-2020
Figure Global Pneumonia Vaccine Market Share by Types in 2019
Table Different Applications of Pneumonia Vaccine
Figure Global Pneumonia Vaccine Value ($) Segment by Applications from 2015-2020
Figure Global Pneumonia Vaccine Market Share by Applications in 2019
Figure Global Pneumonia Vaccine Market Share by Regions in 2019
Figure North America Pneumonia Vaccine Production Value ($) and Growth Rate (2015-2020)
Figure Europe Pneumonia Vaccine Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Pneumonia Vaccine Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Pneumonia Vaccine Production Value ($) and Growth Rate (2015-2020)
Figure South America Pneumonia Vaccine Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Pneumonia Vaccine
Table Upstream Raw Material Suppliers of Pneumonia Vaccine with Contact Information
Table Major Players Headquarters, and Service Area of Pneumonia Vaccine
Figure Major Players Production Value Market Share of Pneumonia Vaccine in 2019
Table Major Players Pneumonia Vaccine Product Types in 2019
Figure Production Process of Pneumonia Vaccine
Figure Manufacturing Cost Structure of Pneumonia Vaccine
Figure Channel Status of Pneumonia Vaccine
Table Major Distributors of Pneumonia Vaccine with Contact Information
Table Major Downstream Buyers of Pneumonia Vaccine with Contact Information
Table Global Pneumonia Vaccine Value ($) by Type (2015-2020)
Table Global Pneumonia Vaccine Value Share by Type (2015-2020)
Figure Global Pneumonia Vaccine Value Share by Type (2015-2020)
Table Global Pneumonia Vaccine Production by Type (2015-2020)
Table Global Pneumonia Vaccine Production Share by Type (2015-2020)
Figure Global Pneumonia Vaccine Production Share by Type (2015-2020)
Figure Global Pneumonia Vaccine Value ($) and Growth Rate of Pneumococcal Conjugate Vaccine (PCV13) (2015-2020)
Figure Global Pneumonia Vaccine Value ($) and Growth Rate of Pneumococcal Polysaccharide Vaccine (PPSV23) (2015-2020)
Figure Global Pneumonia Vaccine Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Pneumonia Vaccine Consumption by Application (2015-2020)
Table Global Pneumonia Vaccine Consumption Market Share by Application (2015-2020)
Figure Global Pneumonia Vaccine Consumption Market Share by Application (2015-2020)
Figure Global Pneumonia Vaccine Consumption and Growth Rate of Pneumonia (2015-2020)
Figure Global Pneumonia Vaccine Consumption and Growth Rate of Meningitis (2015-2020)
Figure Global Pneumonia Vaccine Consumption and Growth Rate of Sepsis (2015-2020)
Figure Global Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure Global Pneumonia Vaccine Revenue (M USD) and Growth (2015-2020)
Table Global Pneumonia Vaccine Sales by Regions (2015-2020)
Table Global Pneumonia Vaccine Sales Market Share by Regions (2015-2020)
Table Global Pneumonia Vaccine Revenue (M USD) by Regions (2015-2020)
Table Global Pneumonia Vaccine Revenue Market Share by Regions (2015-2020)
Table Global Pneumonia Vaccine Revenue Market Share by Regions in 2015
Table Global Pneumonia Vaccine Revenue Market Share by Regions in 2019
Figure North America Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure Europe Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure South America Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Pneumonia Vaccine Revenue (M USD) and Growth (2015-2020)
Table North America Pneumonia Vaccine Sales by Countries (2015-2020)
Table North America Pneumonia Vaccine Sales Market Share by Countries (2015-2020)
Table North America Pneumonia Vaccine Revenue (M USD) by Countries (2015-2020)
Table North America Pneumonia Vaccine Revenue Market Share by Countries (2015-2020)
Figure United States Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure Canada Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure Mexico Pneumonia Vaccine Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Pneumonia Vaccine Revenue (M USD) and Growth (2015-2020)
Table Europe Pneumonia Vaccine Sales by Countries (2015-2020)
Table Europe Pneumonia Vaccine Sales Market Share by Countries (2015-2020)
Table Europe Pneumonia Vaccine Revenue (M USD) by Countries (2015-2020)
Table Europe Pneumonia Vaccine Revenue Market Share by Countries (2015-2020)
Figure Germany Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure UK Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure France Pneumonia Vaccine Sales and Growth (2015-2020)
Figure Italy Pneumonia Vaccine Sales and Growth (2015-2020)
Figure Spain Pneumonia Vaccine Sales and Growth (2015-2020)
Figure Russia Pneumonia Vaccine Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Pneumonia Vaccine Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Pneumonia Vaccine Sales by Countries (2015-2020)
Table Asia Pacific Pneumonia Vaccine Sales Market Share by Countries (2015-2020)
Table Asia Pacific Pneumonia Vaccine Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Pneumonia Vaccine Revenue Market Share by Countries (2015-2020)
Figure China Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure Japan Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure South Korea Pneumonia Vaccine Sales and Growth (2015-2020)
Figure India Pneumonia Vaccine Sales and Growth (2015-2020)
Figure Southeast Asia Pneumonia Vaccine Sales and Growth (2015-2020)
Figure Australia Pneumonia Vaccine Sales and Growth (2015-2020)
Figure Middle East Pneumonia Vaccine Revenue (M USD) and Growth (2015-2020)
Table Middle East Pneumonia Vaccine Sales by Countries (2015-2020)
Table Middle East and Africa Pneumonia Vaccine Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Pneumonia Vaccine Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Pneumonia Vaccine Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure UAE Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure Egypt Pneumonia Vaccine Sales and Growth (2015-2020)
Figure Nigeria Pneumonia Vaccine Sales and Growth (2015-2020)
Figure South Africa Pneumonia Vaccine Sales and Growth (2015-2020)
Figure South America Pneumonia Vaccine Revenue (M USD) and Growth (2015-2020)
Table South America Pneumonia Vaccine Sales by Countries (2015-2020)
Table South America Pneumonia Vaccine Sales Market Share by Countries (2015-2020)
Table South America Pneumonia Vaccine Revenue (M USD) by Countries (2015-2020)
Table South America Pneumonia Vaccine Revenue Market Share by Countries (2015-2020)
Figure Brazil Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure Argentina Pneumonia Vaccine Sales and Growth Rate (2015-2020)
Figure Columbia Pneumonia Vaccine Sales and Growth (2015-2020)
Figure Chile Pneumonia Vaccine Sales and Growth (2015-2020)
Figure Top 3 Market Share of Pneumonia Vaccine Companies in 2019
Figure Top 6 Market Share of Pneumonia Vaccine Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Serum Institute of India Profile
Table Serum Institute of India Product Introduction
Figure Serum Institute of India Production and Growth Rate
Figure Serum Institute of India Value ($) Market Share 2015-2020
Table Biken Profile
Table Biken Product Introduction
Figure Biken Production and Growth Rate
Figure Biken Value ($) Market Share 2015-2020
Table Genentech Profile
Table Genentech Product Introduction
Figure Genentech Production and Growth Rate
Figure Genentech Value ($) Market Share 2015-2020
Table Eli Lilly Profile
Table Eli Lilly Product Introduction
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Value ($) Market Share 2015-2020
Table Sanofi Profile
Table Sanofi Product Introduction
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2015-2020
Table Celgene Profile
Table Celgene Product Introduction
Figure Celgene Production and Growth Rate
Figure Celgene Value ($) Market Share 2015-2020
Table Merck Profile
Table Merck Product Introduction
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2015-2020
Table S K Chemicals Profile
Table S K Chemicals Product Introduction
Figure S K Chemicals Production and Growth Rate
Figure S K Chemicals Value ($) Market Share 2015-2020
Table Abera Profile
Table Abera Product Introduction
Figure Abera Production and Growth Rate
Figure Abera Value ($) Market Share 2015-2020
Table ImmunoBiology Profile
Table ImmunoBiology Product Introduction
Figure ImmunoBiology Production and Growth Rate
Figure ImmunoBiology Value ($) Market Share 2015-2020
Table Lupin Profile
Table Lupin Product Introduction
Figure Lupin Production and Growth Rate
Figure Lupin Value ($) Market Share 2015-2020
Table Pfizer Profile
Table Pfizer Product Introduction
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table Panacea Biotec (India) Profile
Table Panacea Biotec (India) Product Introduction
Figure Panacea Biotec (India) Production and Growth Rate
Figure Panacea Biotec (India) Value ($) Market Share 2015-2020
Table Nuron Biotech Profile
Table Nuron Biotech Product Introduction
Figure Nuron Biotech Production and Growth Rate
Figure Nuron Biotech Value ($) Market Share 2015-2020
Table Baxter Profile
Table Baxter Product Introduction
Figure Baxter Production and Growth Rate
Figure Baxter Value ($) Market Share 2015-2020
Table GlaxoSmithKline (GSK) Profile
Table GlaxoSmithKline (GSK) Product Introduction
Figure GlaxoSmithKline (GSK) Production and Growth Rate
Figure GlaxoSmithKline (GSK) Value ($) Market Share 2015-2020
Table AstraZeneca Profile
Table AstraZeneca Product Introduction
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Value ($) Market Share 2015-2020
Table Biogen Profile
Table Biogen Product Introduction
Figure Biogen Production and Growth Rate
Figure Biogen Value ($) Market Share 2015-2020
Table Valneva Austria Profile
Table Valneva Austria Product Introduction
Figure Valneva Austria Production and Growth Rate
Figure Valneva Austria Value ($) Market Share 2015-2020
Table Beijing Minhai Biotechnology Profile
Table Beijing Minhai Biotechnology Product Introduction
Figure Beijing Minhai Biotechnology Production and Growth Rate
Figure Beijing Minhai Biotechnology Value ($) Market Share 2015-2020
Table Genocea Biosciences Profile
Table Genocea Biosciences Product Introduction
Figure Genocea Biosciences Production and Growth Rate
Figure Genocea Biosciences Value ($) Market Share 2015-2020
Table Sinovac Profile
Table Sinovac Product Introduction
Figure Sinovac Production and Growth Rate
Figure Sinovac Value ($) Market Share 2015-2020
Table Market Driving Factors of Pneumonia Vaccine
Table Merger, Acquisition and New Investment
Table Global Pneumonia Vaccine Market Value ($) Forecast, by Type
Table Global Pneumonia Vaccine Market Volume Forecast, by Type
Figure Global Pneumonia Vaccine Market Value ($) and Growth Rate Forecast of Pneumococcal Conjugate Vaccine (PCV13) (2020-2025)
Figure Global Pneumonia Vaccine Market Volume ($) and Growth Rate Forecast of Pneumococcal Conjugate Vaccine (PCV13) (2020-2025)
Figure Global Pneumonia Vaccine Market Value ($) and Growth Rate Forecast of Pneumococcal Polysaccharide Vaccine (PPSV23) (2020-2025)
Figure Global Pneumonia Vaccine Market Volume ($) and Growth Rate Forecast of Pneumococcal Polysaccharide Vaccine (PPSV23) (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Pneumonia (2020-2025)
Figure Market Volume and Growth Rate Forecast of Pneumonia (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Meningitis (2020-2025)
Figure Market Volume and Growth Rate Forecast of Meningitis (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Sepsis (2020-2025)
Figure Market Volume and Growth Rate Forecast of Sepsis (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|